Medtronic plc (NYSE: MDT), a global leader in healthcare technology, announces it has completed its acquisition of Scientia Vascular, a privately-held medical device company in Salt Lake City. The acquisition is valued at $550 million, subject to customary adjustments, with potential undisclosed earn-out and milestone payments post-acquisition. Scientia has developed best-in-class access products that enable simplicity and access for physicians treating complex neurovascular conditions. Scientia’s portfolio of guidewires and catheters can be seamlessly integrated with Medtronic’s existing suite of neurovascular products, strengthening the company’s ability to support physicians across the full procedural workflow.
Read the full article: Medtronic Completes Acquisition of Scientia Vascular //
Source: https://news.medtronic.com/2026-06-12-Medtronic-completes-acquisition-of-Scientia-Vascular,-seamlessly-integrating-access-and-therapeutic-portfolios-for-neurovascular-care